Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
The Company was previously affiliated with PerkinElmer, Inc.
Revvity, Inc.
“The unveiling of Revvity is the capstone of a nearly year-long journey that has transformed who we are and reinforces why our work matters,” said Prahlad Singh, president and chief executive officer of Revvity. “At Revvity, we are united with our customers to impact health across the lifespan. Our purpose is to expand the boundaries of human potential through science. We view the challenges facing our customers as a call to action.”
Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech, diagnostic labs, academia and government agencies. “We’re a translational company in the sense that our capabilities facilitate decision making between research and clinical customers,” remarked Singh. “With cross-business collaborations between our automation, multi-omics offerings, and our Signals software business, we have unique capabilities which put us in an optimal position to accelerate breakthrough solutions – starting with preclinical research and scientific discovery, all the way through to diagnosing and helping to treat disease.”
Changes to Brand Architecture
- Industry leading franchises, BioLegend, EUROIMMUN, Tulip Diagnostics and ViaCord retain their own names as unique product lines.
- The Company’s comprehensive scientific software platform, previously known as PerkinElmer Informatics, will become Revvity Signals Software, Inc.
- Revvity Omics replaces PerkinElmer Genomics as the Company's genomics services business.
- Cisbio, Horizon Discovery, Nexcelom Bioscience, Omni International, Oxford Immunotec, SIRION Biotech and SonoVol will now identify as Revvity, while maintaining their specific product names.
What’s ahead?
- The Company will trade under its new name and the stock ticker symbol "RVTY” at market open on May 16, 2023. At the same time its 1.875% Notes due 2026 will begin trading under “RVTY 26.” Members of the Revvity team will commemorate the new name, brand and stock ticker by ringing the bell that morning at the New York Stock Exchange.
- Roadshows intended for existing and prospective customers will be scheduled in select global markets to introduce the ne
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.